QNCX Quince Therapeutics Q4 loss balloons to minus 71 dollars per share shocking investors with 2687 percent miss FRMEP First reports narrow Q4 2025 EPS beat shares dip 082 on soft investor sentiment Lam LRCX Stock Risk Assessment Overview Technical Weakness 20260420 AIR AAR Corp releases quarterly earnings report with comprehensive financial breakdown and strategic outlook commentary What you need to know before buying SkyWater Technology SKYT Slight Rise 20260511